Marjorie Davison
Family · Decatur, GANPI 1285152132
Payments from drug & device makers
Across 129 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$589
- Lilly USA, LLC$345
- Abbott$300
- Xeris Pharmaceuticals, Inc.$190
- Mannkind Corporation$140
- Amgen$77
- plus $623 from 17 others
What the payments were for
- Food & beverage$2,263100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 50 | $589 |
| Lilly USA, LLC | 18 | $345 |
| Abbott | 6 | $300 |
| Xeris Pharmaceuticals, Inc. | 10 | $190 |
| Mannkind Corporation | 6 | $140 |
| Amgen | 4 | $77 |
| Dexcom, Inc. | 4 | $70 |
| Merck | 4 | $67 |
| AstraZeneca | 5 | $66 |
| Boehringer Ingelheim | 3 | $59 |
| Radius Health, Inc. | 3 | $56 |
| Ultragenyx Pharmaceutical Inc. | 2 | $54 |
| Amneal Pharmaceuticals LLC | 2 | $46 |
| Medtronic | 2 | $30 |
| AbbVie | 2 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Novartis | 1 | $20 |
| Insulet Corporation | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $20 |
| Nevro Corp. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,263 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 629 | $735,974 |
| JardianceEmpagliflozin | 354 | $318,013 |
| FarxigaDapagliflozin Propanediol | 107 | $96,628 |
| Tresiba Flextouch U-100Insulin Degludec | 154 | $88,379 |
| MounjaroTirzepatide | 48 | $78,686 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 52 | $72,512 |
| Tresiba Flextouch U-200Insulin Degludec | 42 | $72,141 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 59 | $69,469 |
| TrulicityDulaglutide | 45 | $65,830 |
| RybelsusSemaglutide | 52 | $58,618 |
| Novolog FlexpenInsulin Aspart | 170 | $42,797 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $35,576 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 21 | $30,424 |
| Humalog Kwikpen U-100Insulin Lispro | 104 | $26,145 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 53 | $24,707 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $589 | $798,329697 claims |
| Boehringer IngelheimJardiance | $59 | $318,013354 claims |
| Lilly USA, LLCMounjaro, Trulicity | $345 | $144,51693 claims |
| AstraZenecaFarxiga | $66 | $96,628107 claims |
| MerckJanuvia, Janumet | $67 | $22,34625 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $46 | $3,409335 claims |
| AbbVieSynthroid | $24 | $2,76334 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.
Other family in Decatur
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.